SCHEMBL21264665

SCHEMBL21264665

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4n4c5cc(-n6c7ccccc7n7c8ccccc8cc67)ccc5cc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
MAPK1 P28482 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
KMT2A Q03164 6/20 0.33
MEN1 O00255 5/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
ADORA1 P30542 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ADORA2A P29274 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 2/20 0.31
TSHR P16473 2/20 0.31
AGTR1 P30556 1/20 0.31
ATM Q13315 1/20 0.31
NTSR1 P30989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21264803 0.95 MAPT (0.34) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264823 0.90 L3MBTL1 (0.36) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264695 0.89 L3MBTL1 (0.32) MAPTL3MBTL1MAPK1KDM4EKMT2A
SCHEMBL21264865 0.88 RAC2 (0.35) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264542 0.87 L3MBTL1 (0.36) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264683 0.86 ESR1 (0.33) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264666 0.86 KDM4E (0.30) MAPTL3MBTL1MAPK1NPSR1KDM4E
SCHEMBL21264849 0.84 ESR1 (0.32) MAPTMAPK1KDM4EALDH1A1HPGD
SCHEMBL21264805 0.84 ESR1 (0.32) MAPTMAPK1KDM4EALDH1A1HPGD
SCHEMBL21264678 0.84 L3MBTL1 (0.32) MAPTL3MBTL1MAPK1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190252623-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190252623-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ZYX, NSD3, NES MAPT 4481/4885L3MBTL1 923/4885MAPK1 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.